From: Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors
Cell name | CD90+/CD90− | Cytokines | Functions | References |
---|---|---|---|---|
Myometrial and orbital fibroblasts | CD90+ | – | Differentiate into myofibroblasts | Koumas et al. (2003) |
CD90− | Differentiate into adipose fibroblasts | |||
Lung fibroblast | CD90+ | PDGF, IL-1β, IL-4, TGF-β, Smad3, α-SMA | Inhibit differentiation into myofibroblasts | Yang et al. (2020) |
CD90− | Differentiate into myofibroblasts | |||
Embryo fibroblast | CD90+ | FGF1 | Inducing angiogenesis | Hoseini et al. (2017), Jacobs et al. (2016), Bourgine et al. (2019) |
Melanoma fibroblasts | CD90+ | COL1A1 | Inducing angiogenesis | Goldstein et al. (2005) |
Esophageal cancer fibroblasts | CD90+ | FAP, SMA, COL1A1, COL3A1 | Inducing angiogenesis | Krämer et al. (2020) |
Colorectal cancer fibroblasts | CD90+ | CCL5, SLC25A24, pAkt, pmTOR | Inducing angiogenesis | |
Dermal fibroblasts | CD90+ | ITGβ3, FasL | Promote apoptosis and maintain skin homeostasis | Schmidt et al. (2016) |
Peritoneal fibroblasts | CD90+ | TGF-β1 | Promote cell proliferation, leading to fibrotic thickening of the peritoneum | Kawka et al. (2017) |
Synovioblast | CD90+ | IL-6, CXCL12, ISG, NOTCH3, IL-1RI, IL-1β | Inducing high inflammation | Huang et al. (2009) |